WallStSmart
DCTH

Delcath Systems Inc

NASDAQ: DCTH · HEALTHCARE · MEDICAL DEVICES

$13.01
-3.77% today

Updated 2026-07-10

Market cap
$446.71M
P/E ratio
1,294.00
P/S ratio
4.94x
EPS (TTM)
$0.01
Dividend yield
52W range
$8 – $13
Volume
0.5M

Delcath Systems Inc (DCTH) Stock Valuation Analysis

Fair value estimate, historical valuation range, and quality signals for DCTH.

WallStSmart Verdict
Overvalued

Current price exceeds what fundamentals support. Risk/reward skewed unfavorably.

Smart Value Score: 35 / 100
P/E (TTM)
1294.0x
vs 5Y median of 152.1x
PEG
1.60
Fair range
Margin of Safety
DCF limited for this profile
EV / EBITDA
294.2x

DCTH historical valuation range

Where current P/E sits in DCTH's own 5Y range.

NOW
143.4x
5Y Low
147.3x
25th
152.1x
Median
155.7x
75th
159.9x
5Y High
DCTH is trading more expensive than 100% of the last 5Y.
100th percentile · Historically expensive

DCTH intrinsic value (DCF)

DCF-based fair value estimate vs current market price.

DCF has limited applicability for DCTH

Standard discounted cash flow models produce unreliable output for unprofitable or near-breakeven companies. Revenue-based multiples such as P/S and EV/Sales, combined with the historical valuation position above, give a more reliable read for this stock.

Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.

DCTH valuation signals

Quick-read green flags, caution flags, and risks based on current metrics.

!
PEG in fair range
PEG of 1.60 suggests price reflects growth fairly. Neither a bargain nor overpriced.
P/E near 5Y high
Current P/E sits in the 100th percentile of its 5Y range. Historically expensive relative to its own history.
!
DCF limited applicability
Company profile produces unstable DCF output. Lean on P/S, EV/Sales, and historical valuation position instead of intrinsic value for this stock.

P/E Ratio — History

Current: 1294.00x

P/S Ratio — History

Current: 4.94x

Is DCTH overvalued in 2026?

Delcath Systems Inc (DCTH) currently trades at $13.01 per share with a market capitalization of $446,710,000.00. Based on our multi-factor framework, the stock appears richly valued with a Smart Value Score of 35/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.

The stock trades at a P/E ratio of 1294.0x, above its 5-year median of 152.1x. The PEG ratio of 1.60 points to a price that reasonably reflects expected earnings growth.

Looking at its own history, DCTH is currently trading more expensive than 100% of the last 5Y on P/E. This places it in the 100th percentile of its historical range, a zone where forward returns have typically been muted.

A standard DCF model does not produce reliable output for DCTH under current conditions. For unprofitable or near-breakeven companies, revenue-based multiples such as EV/Sales and historical P/S percentile are more informative than intrinsic value calculations.

The Piotroski F-Score of 4/9 puts financial quality in a middling range, neither a standout strength nor an obvious red flag.

Bottom line: DCTH appears richly valued on our framework, with a Smart Value Score of 35/100. At current levels the risk/reward is skewed against the buyer. A materially lower price or significant operational improvement would be needed to change the picture.

Frequently asked questions

Is DCTH overvalued?

DCTH scores 35/100 on our Smart Value Score (Grade D), a weak overall profile. A standard DCF is unreliable here given the profitability profile, so valuation leans on revenue-based measures like EV/Sales and the P/S percentile below.

What is DCTH's fair value?

A standard DCF is unreliable for DCTH given its current profitability profile. Revenue-based approaches like EV/Sales or the historical P/S percentile are more informative for this stock.

What P/E ratio does DCTH trade at?

DCTH trades at a P/E of 1294.0x on trailing twelve-month earnings, against a 5-year median of 152.1x. P/E is what you pay per dollar of profit, and sitting above its own median means the stock is pricier than usual relative to its earnings.

Is DCTH a buy based on valuation?

Our Smart Value rating for DCTH is Sell, from a Smart Value Score of 35/100 that blends growth, quality, and valuation. The profile skews cautious, and a better price or clearer operating improvement would strengthen the case. This is research to inform your decision, not personalized financial advice.

How does DCTH's valuation compare to its history?

On P/E, DCTH sits in the 100th percentile of its own 5Y range, historically expensive relative to where it has traded. A high percentile means today's multiple is near the top of its historical band.

What is DCTH's Smart Value Score?

DCTH's Smart Value Score is 35/100. It is a proprietary WallStSmart metric blending growth quality, financial health, and valuation into a single 0-100 read, and scores above 75 are rare, signaling strong multi-factor alignment.